C W Boone1, R Lieberman, T Mairinger
1National Cancer Institute, Bethesda, Maryland, USA.
Identifying early prostate cancer changes using nuclear chromatin patterns can validate chemoprevention efficacy. Biomarkers detect subtle alterations, aiding in assessing treatment effectiveness for slow-progressing lesions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: